Recent evidence suggests that miR-302a exerts antiproliferative and pro-apoptotic effects in HCC cells by targeting both MAP3K2 and PBX3 (Figure 3a) [74]. The gene discussed is MAP3K2; the disease is hepatocellular carcinoma.